• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟酰胺在LEC大鼠中的代谢命运。

Metabolic fate of nicotinamide in LEC rats.

作者信息

Shibata K, Onodera M, Taniguchi M, Taniguchi N

机构信息

Department of Food Science and Nutrition, Osaka International University for Women, Japan.

出版信息

Biochem Int. 1992 Mar;26(3):389-95.

PMID:1385704
Abstract

Metabolic fates of nicotinamide in Wistar and LEC rats were compared. In Wistar rats (normal rats) nicotinamide was generally catabolized to N1-methyl-4-pyridone-3-carboxamide (4-Py) through N1-methylnicotinamide (MNA). But in LEC rats nicotinamide catabolism mainly stopped at MNA. Therefore, the excretion ratio of (N1-methyl-2-pyridone-5-carboxamide + 4-Py)/MNA, which is an index of amino acid adequacy, was much lower in the LEC rats than in the Wistar rats. This phenomenon was attributed to the fact that the 4-Py-forming MNA oxidase activity was much lower in the LEC rats than in the Wistar rats. The NAD contents in liver and blood were also lower in LEC rats than in Wistar rats. These results suggest that the ability to synthesize proteins such as 4-Py-forming MNA oxidase and dehydrogenases may be impaired in LEC rats.

摘要

比较了烟酰胺在Wistar大鼠和LEC大鼠体内的代谢命运。在Wistar大鼠(正常大鼠)中,烟酰胺通常通过N1-甲基烟酰胺(MNA)分解代谢为N1-甲基-4-吡啶酮-3-甲酰胺(4-Py)。但在LEC大鼠中,烟酰胺的分解代谢主要停留在MNA阶段。因此,作为氨基酸充足指标的(N1-甲基-2-吡啶酮-5-甲酰胺 + 4-Py)/MNA排泄率,LEC大鼠比Wistar大鼠低得多。这种现象归因于LEC大鼠中生成4-Py的MNA氧化酶活性比Wistar大鼠低得多。LEC大鼠肝脏和血液中的NAD含量也比Wistar大鼠低。这些结果表明,LEC大鼠合成诸如生成4-Py的MNA氧化酶和脱氢酶等蛋白质的能力可能受损。

相似文献

1
Metabolic fate of nicotinamide in LEC rats.烟酰胺在LEC大鼠中的代谢命运。
Biochem Int. 1992 Mar;26(3):389-95.
2
Comparison of the nicotinamide catabolism among rat strains.大鼠品系间烟酰胺分解代谢的比较。
Biosci Biotechnol Biochem. 2009 Feb;73(2):274-9. doi: 10.1271/bbb.80372. Epub 2009 Feb 7.
3
Fate of excess nicotinamide and nicotinic acid differs in rats.大鼠体内过量烟酰胺和烟酸的代谢命运有所不同。
J Nutr. 1989 Jun;119(6):892-5. doi: 10.1093/jn/119.6.892.
4
Fate of nicotinamide differs due to an intake of nicotinamide.由于烟酰胺的摄入,烟酰胺的命运有所不同。
Biosci Biotechnol Biochem. 1996 Jul;60(7):1204-6. doi: 10.1271/bbb.60.1204.
5
The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production.人类肝硬化中烟酰胺的代谢:关于N-甲基烟酰胺和2-吡啶酮-5-甲酰胺生成的研究
Am J Gastroenterol. 2001 Apr;96(4):1183-7. doi: 10.1111/j.1572-0241.2001.03698.x.
6
Changes in Nicotinamide Metabolism by One Amino Acid Deficiency. (I) Threonine-, Tryptophan-, Aspartic Acid-, Lysine-, Leucine-, or Methionine-free Diet.
Biosci Biotechnol Biochem. 1992 Jan;56(5):783-7. doi: 10.1271/bbb.56.783.
7
Effect of supplementing low protein diets with the limiting amino acids on the excretion of N1-methylnicotinamide and its pyridones in rats.用限制性氨基酸补充低蛋白饮食对大鼠N1-甲基烟酰胺及其吡啶酮排泄的影响。
J Nutr. 1989 Jun;119(6):896-901. doi: 10.1093/jn/119.6.896.
8
Enzymes that control the conversion of L-tryptophan-nicotinamide and the urinary excretion ratio (N(1)-methyl-2-pyridone-5-carboxamide + N(1)-methyl-4-pyridone-3-carboxamide)/N(1)-methylnicotinamide in mice.控制小鼠体内L-色氨酸-烟酰胺转化以及尿排泄率(N(1)-甲基-2-吡啶酮-5-甲酰胺 + N(1)-甲基-4-吡啶酮-3-甲酰胺)/N(1)-甲基烟酰胺的酶。
Biosci Biotechnol Biochem. 2013;77(10):2105-11. doi: 10.1271/bbb.130467. Epub 2013 Oct 7.
9
Correlation between niacin equivalent intake and urinary excretion of its metabolites, N'-methylnicotinamide, N'-methyl-2-pyridone-5-carboxamide, and N'-methyl-4-pyridone-3-carboxamide, in humans consuming a self-selected food.食用自选食物的人群中烟酸当量摄入量与其代谢产物N'-甲基烟酰胺、N'-甲基-2-吡啶酮-5-羧酰胺和N'-甲基-4-吡啶酮-3-羧酰胺尿排泄量之间的相关性。
Am J Clin Nutr. 1989 Jul;50(1):114-9. doi: 10.1093/ajcn/50.1.114.
10
Comparison of metabolic fates of nicotinamide, NAD+ and NADH administered orally and intraperitoneally; characterization of oral NADH.口服和腹腔注射烟酰胺、NAD⁺和NADH的代谢命运比较;口服NADH的特性
J Nutr Sci Vitaminol (Tokyo). 2006 Apr;52(2):142-8. doi: 10.3177/jnsv.52.142.